Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Pennant Group Inc-The Market Cap
Based on ratings from 0 stock analysts, the Pennant Group Inc-The stock price is expected to decrease by 9.14% in 12 months. This is calculated by using the average 12-month stock price forecast for Pennant Group Inc-The. The lowest target is $26 and the highest is $34. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assignedPNTG 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Pennant Group Inc-The to sell. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on PNTG. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of PNTG.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| David Macdonald Truist Securities | Hold | $34 | Maintains | Aug 15, 2024 |
| Scott Fidel Stephens & Co. | Overweight | $32 | Maintains | Aug 8, 2024 |
| Michael Wiederhorn Oppenheimer | Outperform | $34 | Maintains | Aug 8, 2024 |
| David Macdonald Truist Securities | Hold | $28 | Maintains | Jul 15, 2024 |
| Scott Fidel Stephens & Co. | Overweight | $25 | Reiterates | Jun 20, 2024 |
| David Macdonald Truist Securities | Hold | $25 | Maintains | May 15, 2024 |
| Ben Hendrix RBC Capital | Outperform | $26 | Maintains | May 9, 2024 |
| Scott Fidel Stephens & Co. | Overweight | $23 | Reiterates | May 7, 2024 |
| David Macdonald Truist Securities | Hold | $21 | Maintains | Mar 1, 2024 |
| Michael Wiederhorn Oppenheimer | Outperform | $22 | Maintains | Mar 1, 2024 |
| Michael Wiederhorn Oppenheimer | Outperform | $18 | Maintains | Jan 17, 2024 |
| Scott Fidel Stephens & Co. | Overweight | $18 | Reiterates | Jan 10, 2024 |
| Scott Fidel Stephens & Co. | Overweight | $18 | Upgrade | Jan 5, 2024 |
| David Macdonald Truist Securities | Hold | $14 | Maintains | Nov 9, 2023 |
| Scott Fidel Stephens & Co. | Equal-Weight | $14 | Reiterates | Oct 10, 2023 |
| Scott Fidel Stephens & Co. | Equal-Weight | $14 | Reiterates | Sep 21, 2023 |
| Scott Fidel Stephens & Co. | Equal-Weight | $14 | Reiterates | Sep 12, 2023 |
| Scott Fidel Stephens & Co. | Equal-Weight | $16 | Reiterates | Jul 12, 2023 |
Stephens & Co. | Equal-Weight | Reiterates | Jun 9, 2023 | |
| Scott Fidel Stephens & Co. | Equal-Weight | $16 | Reiterates | May 23, 2023 |
When did it IPO
N/A
Staff Count
5,791
Country
United States
Sector/Industry
Healthcare/Medical Care Facilities
CEO
Mr. Brent J. Guerisoli
Market Cap
$1.04B
In 2023, PNTG generated $544.9M in revenue, which was a increase of 15.14% from the previous year. This can be seen as a signal that PNTG's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
No news data available.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
